logo

RBOT

Vicarious Surgical·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

RBOT fundamentals

Vicarious Surgical (RBOT) released its earnings on Nov 12, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -1.91 (YoY +33.68%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-1.91
+33.68%
Report date
Nov 12, 2025
RBOT Earnings Call Summary for Q3,2025
  • 2026 Design Freeze On Track: Despite 15% workforce reduction, maintaining clinical trial timelines via targeted outsourcing.
  • $10M+ Annualized Cost Savings: 35% YoY expense reduction, with 2026 burn target <$40M.
  • Surgeon-Tested Efficiency: 65% reduction in complex surgical procedures, validating commercial viability.
  • Transparency Boost: Weekly LinkedIn updates to replace quarterly earnings calls for real-time progress.
EPS
Revenue

Revenue & Expenses

Key Indicators

Vicarious Surgical (RBOT) key financial stats and ratios, covering profitability, financial health, and leverage.
Vicarious Surgical (RBOT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Vicarious Surgical (RBOT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Vicarious Surgical (RBOT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Vicarious Surgical (RBOT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Vicarious Surgical (RBOT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield